| 000 | 02092cam a22003974a 4500 | ||
|---|---|---|---|
| 999 |
_c8633 _d8633 |
||
| 001 | 14140219 | ||
| 003 | OSt | ||
| 005 | 20200303151523.0 | ||
| 008 | 051013s2006 nyua b 001 0 eng | ||
| 010 | _a 2005055881 | ||
| 016 | 7 |
_a101259857 _2DNLM |
|
| 020 | _a1574448277 (alk. paper) | ||
| 020 | _a9781574448276 | ||
| 035 | _a(OCoLC)ocm62123300 | ||
| 040 |
_aDNLM/DLC _cDLC _dYDX _dNLM _dBAKER _dMUQ _dDLC |
||
| 042 | _apcc | ||
| 050 | 0 | 0 |
_aRC377 _b.H287 2006 |
| 060 | 1 | 0 |
_aW1 _bNE33LD v.80 2006 |
| 060 | 1 | 0 |
_aWL 360 _bH236 2006 |
| 082 | 0 | 0 |
_a616.834 COO _223 |
| 245 | 0 | 0 |
_aHandbook of multiple sclerosis / _cedited by Stuart D. Cook. |
| 250 | _a4th ed. | ||
| 260 |
_aNew York : _bTaylor & Francis, _c2006. |
||
| 300 |
_axix, 511 p. : _bill. (some col.) ; _c27 cm. |
||
| 490 | 1 |
_aNeurological disease and therapy ; _v80 |
|
| 504 | _aIncludes bibliographical references and index. | ||
| 505 | _aEtiopathegenesis and Epidemiology: Clues to Etiology. Genetics: Susceptibility and Expressivity. Evidence for An Infectious Etiology. An autoimmune disease of the CNS? Clinical Features of MS. MRI Techniques in MS: Role in Diagnosis, Pathophysiology and Therapy. MS Biomarkers. Evoked Potentials. Managing the Symptoms of MS. Rehabilitation: Its Role in MS. Acute Treatments. Treatment of the Clinically Isolated Syndrome. The Use of Interferon Beta. Glatiramer Acetate. Mitoxantrone. Monoclonal Antibodies, T-Cell Receptors, and T-Cell Vaccines. Immune Therapy: Altered Peptide Ligands and Statins. Immunosuppression. Combination Therapy. Regeneration Strategies. Axonal Injury. | ||
| 650 | 0 |
_aMultiple sclerosis _vHandbooks, manuals, etc. |
|
| 650 | 1 | 2 | _aMultiple Sclerosis. |
| 700 | 1 | _aCook, Stuart D. | |
| 830 | 0 |
_aNeurological disease and therapy ; _vv. 80. |
|
| 856 | 4 | 2 |
_3Publisher description _uhttp://www.loc.gov/catdir/enhancements/fy0668/2005055881-d.html |
| 906 |
_a7 _bcbc _corignew _d1 _eocip _f20 _gy-gencatlg |
||
| 942 |
_2ddc _cRFT |
||